About the role:
As a Senior Business Development Manager, you will play a critical role in sourcing, negotiating, and delivering antibody discovery and humanisation services to academic groups and biotechnology partners, contributing to LifeArc’s financial sustainability.
Wes Streeting, Secretary of State for Health and Social Care Marks Official Launch of Health Innovation Hub
Glasgow’s newest purpose-built life sciences laboratory facility, the Health Innovation Hub (HiH), has been officially opened by Wes Streeting, Secretary of State for Health and Social Care following a launch event (5 March). This marks a major milestone for Scotland’s life sciences and the healthcare innovation ecosystem in Glasgow City Region.
About the Role:
We’re pleased to share our latest learning opportunities, including newly added training courses and upcoming webinars designed to support professionals across the life sciences sector. Whether you’re looking to build new skills or deepen your expertise, explore the options below and find the right learning opportunity for you.
________________________________________________
One Nucleus Training
A podcast for the rising stars of the start-up community
Marks & Clerk presents a podcast series created specifically for the start-up community, helping founders understand the importance of embedding intellectual property (IP) into their business strategy from day one.
BOSTON, MA and LONDON, UK – March 11, 2026 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, successfully led a search for Syntis Bio, Inc. and is pleased to announce the placement of David Rosenbaum, Ph.D. as Chief Development Officer (CDO).
BioIgnite: Sparking Growth Through Collaboration
Bionow's BioIgnite conference is back for 2026! Bringing together industry and academia to explore emerging innovation, sector initiatives and funding opportunities across life sciences, the bespoke agenda creates a focused environment for insight, discussion and connection.
Why Attend?
Connecting Investors and Innovators in Life Sciences
Whether you're looking to invest in the next breakthrough in life sciences or seeking funding opportunities for your business, BioCap is THE date for your diary!
BioCap offers three exciting opportunities for investors and businesses to connect:
Sandwich, UK - 9 March 2026: SignaCor Therapeutics has been named the winner of Discovery Park's startup growth programme for innovations in cardiovascular health, securing £250k in funding from venture capital firm Zinc. This investment forms part of a £1M seed round expected to close in April.